These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2288179)

  • 1. Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures.
    Hirsh J
    Acta Chir Scand Suppl; 1990; 556():30-5. PubMed ID: 2288179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep vein thrombosis prophylaxis in the outpatient setting: preventing complications following hospital discharge.
    Turpie AG
    Orthopedics; 1995 Jul; 18 Suppl():15-7. PubMed ID: 7479420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of deep venous thrombosis].
    Verstraete M
    Arch Mal Coeur Vaiss; 1995 Jan; 88(1):73-83. PubMed ID: 7646253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous thromboembolism in high-risk surgical and medical patients.
    Prandoni P; Sabbion P; Tanduo C; Errigo G; Zanon E; Bernardi E
    Semin Vasc Med; 2001; 1(1):61-70. PubMed ID: 15199515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery.
    Lassen MR; Borris LC
    Curr Opin Pulm Med; 1996 Jul; 2(4):300-4. PubMed ID: 9363156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of venous thromboembolism.
    Stringer MD; Kakkar VV
    Herz; 1989 Jun; 14(3):135-47. PubMed ID: 2661385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombosis prophylaxis in orthopaedic surgery: considerations and uncertainties].
    Ettema HB; Hoppener MR; Büller HR; Henny ChP; Verheyen CC
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1842-7. PubMed ID: 14533495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and prevention of venous thromboembolism.
    Storti S; Crucitti P; Cina G
    Rays; 1996; 21(3):439-60. PubMed ID: 9063062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparin.
    Lassen MR; Borris LC
    Orthopedics; 1997 Feb; 20 Suppl():14-7. PubMed ID: 9048402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
    Delis KT; Hunt N; Strachan RK; Nicolaides AN
    Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of thromboembolism in surgery].
    Reilmann H; Bosch U; Barthels M
    Orthopade; 1988 Feb; 17(1):110-7. PubMed ID: 2836777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial clinical experiences with low molecular weight heparin in the prevention of thrombosis in orthopedic surgery].
    Schwarz B; Mittelmeier H
    Aktuelle Traumatol; 1988 Oct; 18(5):226-32. PubMed ID: 2907248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-surgical identification of the patient at risk for developing venous thromboembolism post-operatively.
    Brandjes DP; ten Cate JW; Buller HR
    Acta Chir Scand Suppl; 1990; 556():18-21. PubMed ID: 2288176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures.
    Hirsh J; Levine M
    Br J Clin Pract Suppl; 1989 Jan; 65():2-8. PubMed ID: 2510812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts in the prevention, detection, and treatment of deep vein thrombosis in total hip and knee replacement.
    Yen D
    Curr Opin Rheumatol; 1992 Apr; 4(2):210-5. PubMed ID: 1581150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboprophylaxis in elective orthopaedic surgery -- what is the purpose?
    Prentice CR
    J Bone Joint Surg Br; 1997 Nov; 79(6):889-90. PubMed ID: 9393897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.